09.30SETTING THE SCENE - STABILITY OF materials we put on or in our bodies
10.00THE CHEMICAL BASIS FOR THE STABILITY TESTING OF PHARMACEUTICALS
11.15PHYSICAL ASPECTS OF PRODUCT STABILITY
12.30Lunch13.30 PURPOSEFUL DEGRADATION STUDIES AND THEDEVELOPMENT OF STABILITY-INDICATING METHODOLOGY14.30INTERACTIVE WORKSHOP: THE INSTABILITY OF‘PROFRAGILAZONE’ – ANALYTICAL & FORMULATION DEVELOPMENT STRATEGIES
15.30Coffee and discussion/ networking opportuinity15.45INTERACTIVE WORKSHOP: TEAMS FEEDBACK AND GROUP DISCUSSION
16.45 Workshop Session Report17.00Close of day18.00Welcome Reception19.15Dinner
Tuesday 10 February09.00CHARACTERISING MATERIALS WITH RESPECT TO PHYSICAL STABILITY
10.00STATISTICAL INTREPRETATION OF STABILITY DATA
11.0011.00Coffee and discussion/ networking opportuinity
11.30STABILITY TESTING OF PHARMACEUTICAL DELIVERY DEVICES
12.45Lunch13.45STABILITY TESTING OF BIOTECHNOLOGY PRODUCTS
15.15Coffee and discussion/ networking opportuinity
15.30 WORKSHOP ON PRODUCT PACKAGING
16.30STABILITY TESTING - THE UK AND EUROPEAN REGULATORY PERSPECTIVE
17.30OPEN FORUM - ROUND TABLE DISCUSSION
18.15Close of session19.15Dinner
Wednesday 11 February
08.30INTERNATIONAL ASPECTS OF STABILITY TESTING FOR PRODUCT REGISTRATION
09.30WORKSHOPS IN PARALLEL SESSION
Workshop 1Stability Testing by Contract Research OrganisationsWorkshop 2Establishment of Stability Testing CriteriaWorkshop 3Minimal stability study design for worldwide filing10.20Coffee and discussion/ networking opportuinity10.45FEEDBACK and WORKSHOP REPORTS
11.45PRACTICAL ASPECTS OF STABILITY TESTING
12.45LUNCH
13.45ACCELERATED STABILITY ASSESSMENT PROGRAM (ASAP): USING SCIENCE TO SET SHELF LIFE
15.00Close of course
Organized by:
Royal Pharmaceutical Society of Great Britain
Invited Speakers:
Kevin Ryan,Pfizer
Andy Rignall, AstraZeneca R & D
Graham Leonard, GSL Pharma Consulting
Paul Royall, King’s College London
Sue Smith, AstraZeneca
Alison Sykes, Lonza Biologics
Roy Gray
Sue Harris, Medicines and Healthcare products Regulatory Agency